Article Details

Zacks Investment Research Upgrades Paratek Pharmaceuticals (NASDAQ:PRTK) to Hold

Retrieved on: 2021-03-04 09:16:54

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Upgrades Paratek Pharmaceuticals (NASDAQ:PRTK) to Hold. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 761,220 shares of the specialty pharmaceutical company's stock worth $4,765,000 after buying an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up